Detectable clonal mosaicism in blood as a biomarker of cancer risk in Fanconi anemia
Judith Reina-Castillón(Universitat Pompeu Fabra), Jordi Surrallés(Universitat Autònoma de Barcelona), Juan A. Bueren(Centro de Investigación Biomédica en Red), Albert Català(Hospital Sant Joan de Déu Barcelona), Benjamín Rodríguez‐Santiago(Hospital de Sant Pau), Cristina Beléndez(Hospital General Universitario Gregorio Marañón), Cristina Díaz de Heredia(Universitat Autònoma de Barcelona), Julián Sevilla(University of Southern Denmark), Jean Soulier(Centre National de la Recherche Scientifique), Marcos López‐Sánchez(Universitat Pompeu Fabra), José Antonio Casado(Centre for Biomedical Network Research on Rare Diseases), Isabel Badel(Hospital de Sant Pau), Luis A. Pérez‐Jurado(Instituto de Salud Carlos III), Juan R. González(Universitat Autònoma de Barcelona), Roser Pujol(Universitat Autònoma de Barcelona), Detlev Schindler(University of Würzburg), María Ángeles Dasí(Hospital Universitari i Politècnic La Fe), Miriam Aza‐Carmona(Hospital Universitario La Paz)
Cited by 23
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
|Nature|2010|1.3k
Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells
|Mutagenesis|2010|1.2k
DNA Methylation in Newborns and Maternal Smoking in Pregnancy: Genome-wide Consortium Meta-analysis
|The American Journal of Human Genetics|2016|921